Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
An announcement from Icecure Medical ( (ICCM) ) is now available.
On July 3, 2025, IceCure Medical announced its preliminary financial results for the three and six months ending June 30, 2025. The company reported product sales of approximately $525,000 for the three-month period, with some shipments delayed due to geopolitical tensions but expected to be completed in July. The six-month sales totaled around $1.25 million, a decrease from the previous year. Despite these challenges, IceCure’s operations in the U.S. remained unaffected due to adequate inventory. The company plans to release comprehensive financial results in August 2025.
The most recent analyst rating on (ICCM) stock is a Buy with a $2.50 price target. To see the full list of analyst forecasts on Icecure Medical stock, see the ICCM Stock Forecast page.
Spark’s Take on ICCM Stock
According to Spark, TipRanks’ AI Analyst, ICCM is a Neutral.
Icecure Medical’s score is primarily impacted by ongoing financial struggles, including negative margins and cash flow issues. Technical analysis indicates bearish trends, and the valuation reflects significant challenges due to losses. Although there are positive developments in FDA interactions, they do not outweigh the financial and operational difficulties.
To see Spark’s full report on ICCM stock, click here.
More about Icecure Medical
IceCure Medical, listed on Nasdaq as ICCM, is a company specializing in the development and marketing of advanced cryoablation therapy systems. These systems use liquid nitrogen to destroy tumors by freezing, offering a minimally invasive alternative to traditional surgical tumor removal. The company’s primary focus areas include breast, kidney, bone, and lung cancers, with its flagship ProSense® system being marketed globally.
Average Trading Volume: 246,521
Technical Sentiment Signal: Sell
Current Market Cap: $57.7M
See more insights into ICCM stock on TipRanks’ Stock Analysis page.